Correlation Between BeiGene and Stoke Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BeiGene and Stoke Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BeiGene and Stoke Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BeiGene and Stoke Therapeutics, you can compare the effects of market volatilities on BeiGene and Stoke Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BeiGene with a short position of Stoke Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of BeiGene and Stoke Therapeutics.

Diversification Opportunities for BeiGene and Stoke Therapeutics

-0.61
  Correlation Coefficient

Excellent diversification

The 3 months correlation between BeiGene and Stoke is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding BeiGene and Stoke Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Stoke Therapeutics and BeiGene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BeiGene are associated (or correlated) with Stoke Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Stoke Therapeutics has no effect on the direction of BeiGene i.e., BeiGene and Stoke Therapeutics go up and down completely randomly.

Pair Corralation between BeiGene and Stoke Therapeutics

Given the investment horizon of 90 days BeiGene is expected to under-perform the Stoke Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, BeiGene is 1.64 times less risky than Stoke Therapeutics. The stock trades about -0.3 of its potential returns per unit of risk. The Stoke Therapeutics is currently generating about -0.06 of returns per unit of risk over similar time horizon. If you would invest  1,206  in Stoke Therapeutics on August 24, 2024 and sell it today you would lose (75.00) from holding Stoke Therapeutics or give up 6.22% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy95.65%
ValuesDaily Returns

BeiGene  vs.  Stoke Therapeutics

 Performance 
       Timeline  
BeiGene 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BeiGene has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, BeiGene is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Stoke Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Stoke Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

BeiGene and Stoke Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BeiGene and Stoke Therapeutics

The main advantage of trading using opposite BeiGene and Stoke Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BeiGene position performs unexpectedly, Stoke Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Stoke Therapeutics will offset losses from the drop in Stoke Therapeutics' long position.
The idea behind BeiGene and Stoke Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Insider Screener
Find insiders across different sectors to evaluate their impact on performance